ExAdEx-Innov at IMCAS World Congress 2024

ExAdEx attending IMCAS 2024

ExAdEx-Innov at IMCAS World Congress 2024


IMCAS World Congress is the leading congress in dermatology, plastic surgery and ageing science.

IMCAS congresses are medical research conferences bringing together the latest evidence-based techniques from prominent speakers and the newest developments from the major industry players, with the aim to build a bridge between plastic surgery and cosmetic dermatology, as well as aesthetic surgery, non-invasive aesthetic treatments, clinical dermatology, regenerative medicine and more.

ExAdEx-Innov team has been invited to speak in different sessions about our innovative ExAdEx research and development platform, with applications for the dermatology and aesthetic surgery field:

25th IMCAS World Congress

WHERE: Paris (France)

  • February 1st 2024 / 1:30-3:30 PM / Christian DANI, Scientific Advisor and co-founder
    Session « Lipofilling videorama of latest techniques »
  • February 1st 2024 / 4:00-5:00 PM / Vincent DANI, CEO/CSO and co-founder
    Session « Product analysis: automatic devices for large volume samples »
  • February 2nd 2024 / 2:00-3:30 PM / Luigi FORMICOLA, COO and co-founder
    Session « Innovations in regenerative medecine: industry round table »

For more information about the program, check the congress website here


Latest News

KOL on adipose tissue biology.

Research Director (DR1 INSERM).
Team Leader of « Stem Cells and Differentiation » Lab at Institut de Biologie Valrose (Nice). 

Label of Laboratoire d’Excellence by the French National Research Agency (Investissements pour le Futur, Labex Signalife program). 

Co-inventor of 5 patents

Expert in clinical applications of adipose tissue.

Plastic Reconstructive and Aesthetic Surgeon in Nice.

Member of the Medical Council of Alpes Maritimes region.

Expert for the French National Regulatory Agency ANSM for medical devices.

Certified by French Health Autority HAS (2020-2024).

PhD thesis (2018) on fat tissue and adipose tissue stem cells grafting.

Expert in cell therapy and immunology. 

Senior Lecturer (Maitre de conférences).

Responsible of the Cell and Gene Therapy Unity of Nice University Hospital (CHU de Nice).

Director of « Micoralis » research team at Université Côte d’Azur (Nice).

Founder and CEO of the biotech company Biointerférence (2003-2006).

Co-inventor of 5 patents.

Vincent is responsible of company strategy and technological innovation, thanks to his double skill set in science and deeptech startup development.

With a deep knowledge and vision about ExAdEx technology, Vincent has actively worked as a deeptech entrepreneur to push further the development of breakthrough innovative products around human adipose tissue, which lead him to create ExAdEx-Inov. 

In addition to his entrepreneurial skills, Vincent has a strong background in biology (PhD in Cellular and Molecular Biology from Université Côte d’Azur) and training in clinical research management (CRA training at the Faculty of Medicine of La Timone, Marseille). 

He is co-inventor of the 2 company’s patent families. 

Main areas of expertise: DeepTech entrepreneur; Bioengineering of human adipose tissue. 

Luigi is responsible of the management of company operations and business development strategy, thanks to his expertise in biotech startup development.

With a double competence and training in business and science (including an MBA from IAE Paris Sorbonne Business School and a PhD in Cytological Sciences from Rome University La Sapienza), Luigi has been managing business development and R&D projects in a preclinical CRO and a biotech startup company in previous years. 

He has been supporting ExAdEx-Innov project and business development since his position as an Entrepreneur in Residence for CNRS Innovation Tech Transfer Office in 2021.

Main areas of expertise: Biotech Startup Business Development; Project management